Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001515140-25-000002

Director acquired 2,181 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Holder Michael Director 2025-11-18 Option exercise +2,181 12,359 D
Derivatives
Holder Michael Director 2025-11-18 Option exercise · Restricted Stock Units −2,181 13,819 D
Loading xslF345X05/form4-11202025_111124.xml…